# K142575: Bard RiteCath Intermittent Urinary Catheter

- Pathway: 510(k) (Traditional)
- Applicant: C.R. Bard, Inc.
- Decided: Oct 31, 2014 after 49 days
- Product code: EZD (Catheter, Straight)
- Device class: 2
- Regulation: 21 CFR 876.5130
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 3 generations back to K003784 (2001). 3 ancestors in all.
2 later devices descend from it; 2 cite it directly.
0 of 6 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K133470: Bard Ritecath Intermittent Catheter, C.R. Bard, Inc. (2014) Summary page 4.
- K100878: Self Cath Catheter, Coloplast Manufacturing Us, LLC (2010) Summary page 4.

## Most influential descendants
- K212430: BONREE Nelaton Catheter (2022), 0 descendants of its own
- K170233: Diposable Urinary Catheter (PVC Urinary Catheter, Silicone Urinary Catheter, Latex Urinary Catheter) (2017), 0 descendants of its own

## Indications for use
The Bard RiteCath Intermittent Urinary Catheter is intended for use by adult and pediatric, male and female patients for draining urine from the bladder. Pediatric patients include neonates, infants, children and adolescents.

Source page: https://510kreport.com/device/K142575
Methodology: https://510kreport.com/methodology